Development of a Patient-Specific 3-Dimensional Cell Model to Study Right Heart Failure

A. Llucia-Valldeperas,R. Smal,K. Kurakula,P. Ten Dijke,H. J. Bogaard,A. Vonk-Noordegraaf,M. J. Goumans,F. S. De Man
DOI: https://doi.org/10.1016/j.yjmcc.2018.05.141
IF: 5.763
2020-01-01
Journal of Molecular and Cellular Cardiology
Abstract:Background: Pulmonary arterial hypertension (PAH) is a fatal lung disease with a poor prognosis, characterized by pulmonary vascular remodeling and right ventricle (RV) adaptation to the increasing vascular load. PAH originates in the lungs, however patients eventually die of RV failure, and there is no in vitro model to study it. Therefore, we aim to develop a 3D model of RV failure in PAH by incorporating cardiac cells differentiated from patient derived induced pluripotent stem cells (iPSCs) into an established engineered heart tissue (EHT) approach.
What problem does this paper attempt to address?